Market Overview

Research and Markets: Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/3nx6fw/cervical_cancer) has announced the addition of the "Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018" report to their offering.

This report covers an analysis for cervical cancer diagnostic tests (Pap smear tests, Colposcopy tests and ECC procedures) market. The market is analyzed in terms of number of test results and procedures performed in thousands and revenue in USD thousands. Pap smear testing is a cervical cancer diagnosis method performed on women. It is a preventive measure and is done to test for the presence of cervical cancer in an early stage. Cervical cancer, if detected at an early stage could be treated successfully. An abnormal Pap smear test result leads to the performance of further tests and procedures in order to confirm the presence of cervical cancer.

The cervical cancer diagnostic tests market is segmented on the basis of types into Pap smear tests, Colposcopy tests, and ECC procedures. The number of tests performed and its market revenue is forecasted in this report for Pap smear tests, Colposcopy tests and ECC procedures. The market is also segmented on the basis of geography into three regions namely the U.S, Europe and Asia Pacific. The European region is further segmented into six regions namely: U.K, Germany, Italy, France, Spain and the Rest of Europe. The Asia Pacific market is also sub segmented into three regions namely: India, China and Japan.

This report covers an in depth analysis of the players/companies that exist in the market. A detailed analysis of their business strategies, financial information, company overview, recent developments and SWOT is also included in the report. The market players considered are: Guided Therapeutics, Abott Laboratories, Siemens Healthcare, Ascon Medical Instruments, Olympus, Beckman Coulter Inc, Roche, Cooper Surgical Inc, Cardinal Health and Becton, Dickinson and Company.

We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the cervical cancer diagnostic tests market through the means of primary research to finally come up with our results. This research is specially designed to estimate and analyze the performance in Pap smear testing in a global scenario. This research provides in-depth analysis of Pap smear testing market sales, trend analysis by segments and demand by geography.

The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the global Pap smear tests, Colposcopy tests and ECC procedures market as below:

Cervical Cancer Diagnostic Tests Market by Types:

- Pap Smear Tests

-- Abnormal Pap Smear Tests

- Colposcopy Tests

-- Abnormal Colposcopy Tests

- ECC Procedures

Cervical Cancer Diagnostic Tests Market by Age Group:

- Age 20 - 40

- Age above 40

Companies Mentioned:

- Guided Therapeutics

- Abott Laboratories

- Beckman Coulter INC.

- Becton, Dickinson And Company

- Siemens Healthcare

- Becman Coulter INC.

- Ascon Medical Instruments

- Olympus

- Cardinal Health

- Roche

For more information visit http://www.researchandmarkets.com/research/3nx6fw/cervical_cancer

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics




View Comments and Join the Discussion!